Search Results - "Niogret, Julie"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life by Dalens, Lorraine, Niogret, Julie, Kaderbhai, Courèche Guillaume, Boidot, Romain

    Published in Frontiers in oncology (07-03-2022)
    “…Non-small-cell lung cancer (NSCLC) is one of the main causes of death by cancer worldwide. With the rise of targeted therapies, the search for molecular…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series by Niogret, Julie, Derangère, Valentin, Richard, Corentin, Nuttin, Lisa, Ghiringhelli, François, Favier, Laure, Lefevre, Leila Bengrine, Bergeron, Anthony, Arnould, Laurent, Boidot, Romain

    “…Low-grade serous carcinoma represents a minority of serous carcinoma. Although they have better prognosis than high-grade serous carcinoma, they respond poorly…”
    Get full text
    Journal Article
  5. 5

    Improving olaparib exposure to optimize adverse effects management by Sterlé, Marylise, Puszkiel, Alicja, Burlot, Chloé, Pereira, Eva, Bellesoeur, Audrey, De Percin, Sixtine, Beinse, Guillaume, Fumet, Jean-David, Favier, Laure, Niogret, Julie, Blanchet, Benoit, Royer, Bernard, Bengrine-Lefevre, Leïla, Schmitt, Antonin

    Published in Therapeutic advances in medical oncology (01-01-2024)
    “…Olaparib is an inhibitor of the human poly-(ADP-ribose)-polymerase enzymes (PARP1/2) needed to repair single-strand DNA breaks. It is used in breast, ovarian,…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Associated Factors to Efficacy and Tolerance of Immunotherapy in Older Patients with Cancer Aged 70 Years and Over: Impact of Coprescriptions by Perret, Marie, Bertaut, Aurélie, Niogret, Julie, Marilier, Sophie, Jouanny, Pierre, Manckoundia, Patrick, Bengrine-Lefevre, Leïla, Quipourt, Valérie, Barben, Jérémy

    Published in Drugs & aging (01-09-2023)
    “…Background Immunotherapy with immune checkpoint blockers (ICB) significantly improves the prognosis for an increasing number of cancers. However, data on…”
    Get full text
    Journal Article
  9. 9

    The challenge of ovarian cancer care in the oldest old by Barben, Jérémy, Galvin, Angéline, Kamga, Ariane Mamguem, Bertrand, Nicolas, Niogret, Julie, Tisserand, Julie, Quipourt, Valérie, Bengrine-Lefevre, Leila, Dabakuyo-Yonli, Tienhan Sandrine

    Published in Cancer epidemiology (05-11-2024)
    “…Ovarian cancer (OC) is the eighth most common cancer in women, with a poor prognosis, particularly in older women. The aim of this study was to describe an…”
    Get full text
    Journal Article
  10. 10
  11. 11

    PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports by Collot, Thomas, Niogret, Julie, Carnet, Marion, Chevrier, Sandy, Humblin, Etienne, Favier, Laure, Bengrine-Lefevre, Leila, Desmoulins, Isabelle, Arnould, Laurent, Boidot, Romain

    Published in Molecular medicine reports (01-01-2021)
    “…Loss‑of‑function BRCA mutations are frequent in high‑grade serous ovarian carcinoma. BRCA1 and ‑2 mutations lead to homologous recombination (HR) deficiency…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    EGFR amplification induces sensitivity to antiEGFR therapy in pancreatic acinar cell carcinoma by Richard, Corentin, Niogret, Julie, Boidot, Romain, Ghiringhelli, Francois

    Published in World journal of gastrointestinal oncology (15-04-2018)
    “…Pancreatic acinar cell carcinoma (PACC) is a rare cancer. When the tumor is metastatic, few therapeutic options are available. Precision medicine using…”
    Get full text
    Journal Article
  15. 15

    EGFR amplification induces sensitivity to anti EGFR therapy in pancreatic acinar cell carcinoma by Richard, Corentin, Niogret, Julie, Boidot, Romain, Ghiringhelli, Francois

    Published in World journal of gastrointestinal oncology (15-04-2018)
    “…Pancreatic acinar cell carcinoma (PACC) is a rare cancer. When the tumor is metastatic, few therapeutic options are available. Precision medicine using…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18